Image Guided Surgery Devices Market Regional Revenue, Trends, Opportunities and Future Prospects

The image guided surgery devices market is expected to grow at a CAGR of over 6.5% between 2017-2023.
Rising cases of neurological disorders, increasing prevalence of chronic diseases, increasing geriatric population and surging healthcare expenditure are some of the key drivers for the market growth. Additionally, growing cases of cancer and launch of technologically advanced imaging systems also supports the market growth.



As per the findings of the research, the CT is the largest segment, based on device type, in the image guided surgery devices market. CT is a non-invasive, accurate and fast diagnostic imaging test. It uses x-ray equipment to produce 3D images by taking series of images from different angles. Each image created during the CT procedure shows the bones, tissues and organs in a thin “slice” of the body. It provides cross-sectional images generated during the CT scan and can be reformatted in multiple planes. It is used for diagnosing skeletal abnormalities, blood clots, blood vessel aneurysm and cancer. Neurology has been the largest application area for image guided surgery devices, followed by orthopedic surgery, ENT surgery, oncology surgery and others.

Request for a sample of this research report: https://www.psmarketresearch.com/market-analysis/image-guided-surgery-devices-market/report-sample

Geographically, North America has been the largest market for image guided surgery devices, with the U.S. being the larger contributor to the regional market. Increasing prevalence of neurological disorders, rising geriatric population and adoption of technological advanced imaging techniques are some of the factors that have been driving the growth of the North America image guided surgery devices market. The U.K. has been the largest contributor to the European market for image guided surgery devices, followed by Germany and France. The market is expected to witness the fastest growth in Asia-Pacific, during 2017 - 2023, owing to increasing cases of cancer, arthritis, neurological disorders and rising geriatric population.

Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=image-guided-surgery-devices-market

Some of the key players in the image guided surgery devices market include Siemens AG, GE Healthcare, Koninklijke Philips N.V., Canon Inc., Hitachi, Ltd., KARL STORZ GmbH & Co. KG., Medtronic, Inc., St. Jude Medical, Inc., Varian Medical Systems, Inc., Smith & Nephew plc, Integra LifeSciences Corporation and Zimmer Holdings, Inc.

Prefilled Syringes Market to Witness the Highest Growth Globally in Coming Years

The global prefilled syringes market is growing, due to increasing demand for vaccines, growing geriatric population, increasing prevalence of chronic and lifestyle associated diseases, and increasing healthcare expenditure. In addition, the technological advancement in prefilled syringes, regulations regarding needlestick injuries increases popularity of prefilled syringes, increasing injectable drugs pipeline, and increasing demand for point-of-care administration are also driving the growth of the global market.



The information and data in the publication “Global Prefilled Syringes Market Size, Share, Development, Growth and Demand Forecast to 2020” represent the research and analysis of data from various primary and secondary sources. The top-down approach has been used to calculate the global market size by type. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

Request to sample: https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market/report-sample

The increasing number of self-injection patients and growing demand of biologics and biosimilars are playing a pivotal role in the growth of the global market. Prefilled syringe is a single use, and disposable format packet of parenteral drugs. These are syringes filled with medication, before they are supplied to patients and healthcare providers.

However, strict regulatory requirements, recall of prefilled syringes, interaction of prefilled syringe with drugs, alternative drug delivery methods, and manufacturing complexity and high cost of prefilled syringe act as hindrance in the growth of the global market of prefilled syringes. The increasing combination therapies and customized prefilled syringes are the latest trends observed in this market.

Send Enquiry: https://www.psmarketresearch.com/send-enquiry?enquiry-url=prefilled-syringes-market

In 2014, Europe dominated the global market of prefilled syringes, among all the regions of the global market in terms of volume; whereas, the Asia-Pacific market is expected to witness the fastest growth, with a CAGR of 16.0% during the forecast period in terms of value.

The key companies operating in the global prefilled syringes market include Becton, Dickinson and Company, SCHOTT AG, Gerresheimer AG, Unilife Corporation, Nipro Corporation, Baxter International Inc., West Pharmaceutical Services Inc., Ypsomed Holding AG, Stevanato Group S.p.a., Vetter Pharma-Fretigung GmbH & Co., and Bespak Europe Ltd.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Insulin Delivery Device Market Emerging Technologies, Growth Rate Analysis, Trends and Forecast

The global human insulin market was valued at $23,981.6 million in 2014. The market is expected to grow at a CAGR of 12.5% during the period 2015 to 2020, to reach $48,487.7 million value by 2020. The global human insulin market is being driven by increasing prevalence of diabetic population, and rise in aging population. Diabetes is a chronic and non-communicable disease, and its global prevalence is increasing enormously. Rising prevalence of obesity, rising awareness about diabetic care, and technological advancement in insulin delivery devices are some of the factors driving the growth of the global human insulin market. Growing demand of biosimilar drugs, due to its cost effectiveness, pose an opportunity for the growth of the human insulin market. In addition, increasing usage of insulin pens for the administration of insulin helps to inject the accurate dose of insulin at a time. However, high insulin analog cost and strict regulatory requirements for approval of human insulin are inhibiting the growth of the global human insulin market.



On the basis of type of human insulin, the modern human insulin commands the larger share in the global market. The modern human insulin is also expected to grow at a CAGR (of 13%) than traditional human insulin during 2015 to 2020. The modern human insulin can be further categorized as long acting human insulin, rapid acting human insulin and premixed human insulin; wherein, the long acting human insulin commands the largest share in modern human insulin market but the premixed human insulin exhibited the highest growth rate. The long acting human insulin is prescribed by physicians for the treatment of type 2 diabetes. It is absorbed slowly and works for long time to control the sugar level between meal and sleep. It is administered once or twice a day and the onset time for long acting human insulin is 1 hour, and has its effect for 20 hours to 26 hours.

Download Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/human-insulin-market/report-sample

Increasing prevalence of diabetes, increasing number of geriatric population, rising prevalence of obesity and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America. The North American human insulin market is expected to grow by a CAGR of 11.8% during the period 2015 to 2020. In Europe, according to International Diabetic Federation in 2013, approximately 52 million people were suffering from diabetes in Europe. The European human insulin market is expected to grow by a CAGR of 12.6% during the period 2015 to 2020. Thus, increasing prevalence of diabetes would increase the usage of human insulin.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=human-insulin-market

The global human insulin market has a fragmented structure with large number of companies operating in the market. The key players in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com